Capvizr
THE DEAL, AT A GLANCE

Nanox

From the announcement
01What it doesThe new capital is framed around Deploy 15,000 Nanox ARC units globally under FDA clearance.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02Who is involvedBacked by VariousFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
03What happenedNanox raised $100M Growth RoundFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
04Why it mattersNanox is using growth financing to expand access to medical imaging through an AI digital X-ray device offered as a lower-cost alternative to traditional systems.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Nanox · Financing Record

Explore source-linked visual explanations for Nanox. Unsupported claims are withheld while source review continues.

Record 1106 · Recorded date: Needs review

What it does

Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.

Open record 1106 →

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime